Risek®

Risek®

Therapeutic Segment: Anti-Ulcerant

Generic Name: Omeprazole

Indication:

Capsules

For adults for the treatment of:

  • Gastro-Esophageal Reflux Disease (GERD): treatment of erosive reflux esophagitis, long term management of patients with healed esophagitis to prevent relapse and symptomatic treatment of gastroesophageal reflux disease (GERD).
  • Gastric and duodenal ulcer.
  • Treatment and prophylax is of NSAID-associated ulceration.
  • Eradication of Helicobacter pylori infection associated with peptic ulcer disease.
  • Zollinger-Ellison syndrome.
  • Dyspepsia.
  • Prophylaxis of acid aspiration.

For children over 1 year of age and ≥ 10 kg for:

  • Treatment of reflux oesophagitis.
  • Symptomatic treatment of heartburn and acid regurgitation in gastro-oesophageal reflux disease.

Also, indicated in children and adolescents over 4 years of age in combination with antibiotics in treatment of duodenal ulcer caused by Helicobacter pylori.

Injectable

For patients who are unable to take oral therapy for the short-term (upto 5 days) treatment of:

  • Gastro-oesophageal reflux disease.
  • Peptic ulcer disease.
  • Treatment and prophylaxis of NSAID-associated ulceration.
  • Duodenal ulcer.
  • Zollinger-Ellison syndrome.
  • Prophylaxis of acid aspiration.

Available as:

Capsules
  • 20MG
  • 40MG
Injectable
  • 40MG